OGN - Organon & Co. (OGN) Q4 2023 Earnings Call Transcript
2024-02-15 12:06:05 ET
Organon & Co. (OGN)
Q4 2023 Earnings Conference Call
February 15, 2024, 08:30 AM ET
Company Participants
Jennifer Halchak - Vice President of Investor Relations
Kevin Ali - CEO & Director
Matthew Walsh - Executive VP & CFO
Conference Call Participants
Umer Raffat - Evercore ISI
Jason Gerberry - Bank of America
Navann Ty - BNP Paribas
Balaji Prasad - Barclays
Christopher Schott - JPMorgan
Karishma Raghuram - Goldman Sachs
Presentation
Operator
Thank you for standing by. And welcome to the Organon Q4 Full Year 2023 Earnings Call and Webcast. I would now like to welcome Jennifer Halchak, Vice President of Investor Relations to begin the call. Jennifer, over to you.
Jennifer Halchak
Thank you, operator, and good morning, everyone. Thank you for joining Organon's fourth quarter 2023 and full year 2023 earnings call. With me today are Kevin Ali, Organon's Chief Executive Officer, who will cover strategy and operational highlights; and Matt Walsh, our Chief Financial Officer, who will review performance and guidance.
Also joining us for the Q&A portion of this call is Organon’s new head of R&D Juan Camilo Arjona Ferreira. Today, we will be referencing a presentation that will be visible during this call for those of you on our webcast. The presentation will also be available following this call on the Events & Presentations section of our Organon Investor Relations website at www.organon.com.
Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements. Actual results could differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's business, which are discussed in the company's filings with the Securities and Exchange Commission, including our 10-K and subsequent periodic filings.
In addition, we will discuss certain non-GAAP financial measures on this call, which should be considered a supplement to and not a substitute for financial measures prepared in accordance with GAAP. A reconciliation of these non-GAAP measures to the comparable GAAP measures is included in the press release and conference call presentation.
I would now like to turn the call over to our CEO, Kevin Ali.
Kevin Ali
Good morning, everyone, and thank you, Jen. Welcome to today's call where we'll talk about our 2023 results and provide financial guidance for the full year of 2024. We ended the year with a very strong fourth quarter. Revenue grew 8% both nominally and at constant currency with growth across all of our five geographies and all three franchisees....
Organon & Co. (OGN) Q4 2023 Earnings Call Transcript